Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|13|1261-1269

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.13, 2008-05, pp. : 1261-1269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropsychiatric Systemic Lupus Erythematosus

By  

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 449-457

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of IL-27 in systemic lupus erythematosus

By Pan Hai-Feng   Tao Jin-Hui   Ye Dong-Qing  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 479-484

Informa Healthcare

Access to resources Recommend Favorite

Manage the neuropsychiatric manifestations of systemic lupus erythematosus with mostly empirical treatments

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 5, 2012-05 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

Neuropsychiatric Manifestations in Systemic Lupus Erythematosus: Epidemiology, Pathophysiology and Management

By Postal Mariana   Costallat Lilian T.L.   Appenzeller Simone  

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 721-736

Adis International

Access to resources Recommend Favorite

Therapeutic Targets of Misguided T Cells in Systemic Lupus Erythematosus

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 295-298

Bentham Science Publishers

Access to resources Recommend Favorite